Illinois 2023-2024 Regular Session

Illinois House Bill HB4777 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB4777 Introduced , by Rep. Lindsey LaPointe SYNOPSIS AS INTRODUCED: 305 ILCS 5/5-55 new Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that, notwithstanding any provision of law to the contrary, whenever a licensed health care practitioner prescribes a nonopioid medication for the treatment of acute pain, neither the Department of Healthcare and Family Services nor a managed care organization contracted with the Department shall deny coverage of the nonopioid prescription drug in favor of an opioid prescription drug or require a patient to try an opioid prescription drug prior to providing coverage of the nonopioid prescription drug. Provides that in establishing and maintaining the Illinois Medicaid Preferred Drug List, the Department shall ensure that no nonopioid drug approved by the U.S. Food and Drug Administration for the treatment or management of pain shall be disadvantaged or discouraged with respect to coverage relative to any opioid or narcotic drug for the treatment or management of pain on the Illinois Medicaid Preferred Drug List, where impermissible disadvantaging or discouragement includes, without limitation: designating any such nonopioid drug as a nonpreferred drug if any opioid or narcotic drug is designated as a preferred drug; or establishing more restrictive or more extensive utilization controls, including, but not limited to, more restrictive or more extensive prior authorization or step therapy requirements, for such nonopioid drug than the least restrictive or extensive utilization controls applicable to any such opioid or narcotic drug. Makes the provisions of the amendatory Act applicable to (i) a nonopioid drug immediately upon its approval by the U.S. Food and Drug Administration for the treatment or management of pain, regardless of whether such drug has been reviewed by the Department for inclusion on the Illinois Medicaid Preferred Drug List and (ii) drugs provided under a contract between the Department and a managed care organization. LRB103 37189 KTG 67308 b A BILL FOR 103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB4777 Introduced , by Rep. Lindsey LaPointe SYNOPSIS AS INTRODUCED: 305 ILCS 5/5-55 new 305 ILCS 5/5-55 new Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that, notwithstanding any provision of law to the contrary, whenever a licensed health care practitioner prescribes a nonopioid medication for the treatment of acute pain, neither the Department of Healthcare and Family Services nor a managed care organization contracted with the Department shall deny coverage of the nonopioid prescription drug in favor of an opioid prescription drug or require a patient to try an opioid prescription drug prior to providing coverage of the nonopioid prescription drug. Provides that in establishing and maintaining the Illinois Medicaid Preferred Drug List, the Department shall ensure that no nonopioid drug approved by the U.S. Food and Drug Administration for the treatment or management of pain shall be disadvantaged or discouraged with respect to coverage relative to any opioid or narcotic drug for the treatment or management of pain on the Illinois Medicaid Preferred Drug List, where impermissible disadvantaging or discouragement includes, without limitation: designating any such nonopioid drug as a nonpreferred drug if any opioid or narcotic drug is designated as a preferred drug; or establishing more restrictive or more extensive utilization controls, including, but not limited to, more restrictive or more extensive prior authorization or step therapy requirements, for such nonopioid drug than the least restrictive or extensive utilization controls applicable to any such opioid or narcotic drug. Makes the provisions of the amendatory Act applicable to (i) a nonopioid drug immediately upon its approval by the U.S. Food and Drug Administration for the treatment or management of pain, regardless of whether such drug has been reviewed by the Department for inclusion on the Illinois Medicaid Preferred Drug List and (ii) drugs provided under a contract between the Department and a managed care organization. LRB103 37189 KTG 67308 b LRB103 37189 KTG 67308 b A BILL FOR
2	2	103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB4777 Introduced , by Rep. Lindsey LaPointe SYNOPSIS AS INTRODUCED:
3	3	305 ILCS 5/5-55 new 305 ILCS 5/5-55 new
4	4	305 ILCS 5/5-55 new
5	5	Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that, notwithstanding any provision of law to the contrary, whenever a licensed health care practitioner prescribes a nonopioid medication for the treatment of acute pain, neither the Department of Healthcare and Family Services nor a managed care organization contracted with the Department shall deny coverage of the nonopioid prescription drug in favor of an opioid prescription drug or require a patient to try an opioid prescription drug prior to providing coverage of the nonopioid prescription drug. Provides that in establishing and maintaining the Illinois Medicaid Preferred Drug List, the Department shall ensure that no nonopioid drug approved by the U.S. Food and Drug Administration for the treatment or management of pain shall be disadvantaged or discouraged with respect to coverage relative to any opioid or narcotic drug for the treatment or management of pain on the Illinois Medicaid Preferred Drug List, where impermissible disadvantaging or discouragement includes, without limitation: designating any such nonopioid drug as a nonpreferred drug if any opioid or narcotic drug is designated as a preferred drug; or establishing more restrictive or more extensive utilization controls, including, but not limited to, more restrictive or more extensive prior authorization or step therapy requirements, for such nonopioid drug than the least restrictive or extensive utilization controls applicable to any such opioid or narcotic drug. Makes the provisions of the amendatory Act applicable to (i) a nonopioid drug immediately upon its approval by the U.S. Food and Drug Administration for the treatment or management of pain, regardless of whether such drug has been reviewed by the Department for inclusion on the Illinois Medicaid Preferred Drug List and (ii) drugs provided under a contract between the Department and a managed care organization.
6	6	LRB103 37189 KTG 67308 b LRB103 37189 KTG 67308 b
7	7	LRB103 37189 KTG 67308 b
8	8	A BILL FOR
9	9	HB4777LRB103 37189 KTG 67308 b HB4777 LRB103 37189 KTG 67308 b
10	10	HB4777 LRB103 37189 KTG 67308 b
11	11	1 AN ACT concerning public aid.
12	12	2 Be it enacted by the People of the State of Illinois,
13	13	3 represented in the General Assembly:
14	14	4 Section 5. The Illinois Public Aid Code is amended by
15	15	5 adding Section 5-55 as follows:
16	16	6 (305 ILCS 5/5-55 new)
17	17	7 Sec. 5-55. Coverage for nonopioid medications; pain relief
18	18	8 parity.
19	19	9 (a) Required coverage for nonopioid medications.
20	20	10 Notwithstanding any provision of law to the contrary, whenever
21	21	11 a licensed health care practitioner prescribes a nonopioid
22	22	12 medication for the treatment of acute pain, neither the
23	23	13 Department nor a managed care organization contracted with the
24	24	14 Department shall deny coverage of the nonopioid prescription
25	25	15 drug in favor of an opioid prescription drug or require a
26	26	16 patient to try an opioid prescription drug prior to providing
27	27	17 coverage of the nonopioid prescription drug.
28	28	18 (b) Pain relief parity. In establishing and maintaining
29	29	19 the Illinois Medicaid Preferred Drug List, the Department
30	30	20 shall ensure that no nonopioid drug approved by the U.S. Food
31	31	21 and Drug Administration for the treatment or management of
32	32	22 pain shall be disadvantaged or discouraged with respect to
33	33	23 coverage relative to any opioid or narcotic drug for the
34	34
35	35
36	36
37	37	103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB4777 Introduced , by Rep. Lindsey LaPointe SYNOPSIS AS INTRODUCED:
38	38	305 ILCS 5/5-55 new 305 ILCS 5/5-55 new
39	39	305 ILCS 5/5-55 new
40	40	Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that, notwithstanding any provision of law to the contrary, whenever a licensed health care practitioner prescribes a nonopioid medication for the treatment of acute pain, neither the Department of Healthcare and Family Services nor a managed care organization contracted with the Department shall deny coverage of the nonopioid prescription drug in favor of an opioid prescription drug or require a patient to try an opioid prescription drug prior to providing coverage of the nonopioid prescription drug. Provides that in establishing and maintaining the Illinois Medicaid Preferred Drug List, the Department shall ensure that no nonopioid drug approved by the U.S. Food and Drug Administration for the treatment or management of pain shall be disadvantaged or discouraged with respect to coverage relative to any opioid or narcotic drug for the treatment or management of pain on the Illinois Medicaid Preferred Drug List, where impermissible disadvantaging or discouragement includes, without limitation: designating any such nonopioid drug as a nonpreferred drug if any opioid or narcotic drug is designated as a preferred drug; or establishing more restrictive or more extensive utilization controls, including, but not limited to, more restrictive or more extensive prior authorization or step therapy requirements, for such nonopioid drug than the least restrictive or extensive utilization controls applicable to any such opioid or narcotic drug. Makes the provisions of the amendatory Act applicable to (i) a nonopioid drug immediately upon its approval by the U.S. Food and Drug Administration for the treatment or management of pain, regardless of whether such drug has been reviewed by the Department for inclusion on the Illinois Medicaid Preferred Drug List and (ii) drugs provided under a contract between the Department and a managed care organization.
41	41	LRB103 37189 KTG 67308 b LRB103 37189 KTG 67308 b
42	42	LRB103 37189 KTG 67308 b
43	43	A BILL FOR
44	44
45	45
46	46
47	47
48	48
49	49	305 ILCS 5/5-55 new
50	50
51	51
52	52
53	53	LRB103 37189 KTG 67308 b
54	54
55	55
56	56
57	57
58	58
59	59
60	60
61	61
62	62
63	63	HB4777 LRB103 37189 KTG 67308 b
64	64
65	65
66	66	HB4777- 2 -LRB103 37189 KTG 67308 b HB4777 - 2 - LRB103 37189 KTG 67308 b
67	67	HB4777 - 2 - LRB103 37189 KTG 67308 b
68	68
69	69
70	70
71	71
72	72
73	73	HB4777 - 2 - LRB103 37189 KTG 67308 b